Abstract
Pancreatic cancer, the fourth leading cause of cancer death in the United States, has a negative prognosis because metastasis occurs before symptoms manifest. Although combination therapies are showing improvements in treatment, the survival rate for pancreatic cancer five years post diagnosis is only 8%, stressing the need for new treatments. The receptor for advanced glycation end products (RAGE) has recently emerged as a chemotherapeutic target in KRAS driven pancreatic cancers both for treatment and in chemoprevention. RAGE appears to be an important regulator of inflammatory, stress and survival pathways that lead to carcinogenesis, resistance to chemotherapy, enhanced proliferation and the high metastatic potential of pancreatic cancer. RAGE expression has been demonstrated in pancreatic cancer tumors but not in adjacent epithelial tissues. Its presence is associated with increased proliferation and metastasis. In an effort to identify novel inhibitors of RAGE among our collection of marine-derived secondary metabolites, a cell-based screening assay utilizing flow cytometry was developed. This effort led to the identification of scalarin as the active compound in a marine sponge identified as Euryspongia cf. rosea. Scalar...Continue Reading
References
Feb 14, 1998·Journal of Natural Products·G R PettitR Pettit
Mar 29, 2003·Journal of Natural Products·Sachiko TsukamotoTomihisa Ohta
Nov 18, 2003·The Journal of Biological Chemistry·Thiruvengadam ArumugamCraig D Logsdon
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thiruvengadam ArumugamCraig D Logsdon
Sep 1, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Angelika BierhausPeter P Nawroth
Dec 21, 2006·Journal of the National Cancer Institute·Thiruvengadam ArumugamCraig D Logsdon
Mar 19, 2009·Journal of Translational Medicine·Louis J SparveroMichael T Lotze
Oct 17, 2009·Cell Death and Differentiation·R KangH J Zeh
Mar 3, 2010·Annual Review of Immunology·Gary P SimsAnthony J Coyle
Mar 13, 2010·Autophagy·Kevin N DalbyBulent Ozpolat
Mar 31, 2010·Investigational New Drugs·Esther A GuzmánAmy E Wright
Apr 20, 2010·Clinical Biochemistry·Tomás KrechlerMarta Kalousová
Oct 28, 2010·Autophagy·Rui KangHerbert J Zeh
Feb 15, 2011·Autophagy·Rui KangHerbert J Zeh
Feb 25, 2011·Molecules and Cells·Sun-Ho HanInhee Mook-Jung
Mar 17, 2011·Genes & Development·Shenghong YangAlec C Kimmelman
May 5, 2011·Cancer Research·Li JiaoRachael Z Stolzenberg-Solomon
Feb 23, 2012·British Journal of Pharmacology·Jianguo LinAnping Chen
Sep 21, 2013·Marine Drugs·Georgios KallifatidisAmy E Wright
Nov 7, 2014·International Journal of Molecular Sciences·Yeon-Ju LeeJieun Yun
Oct 18, 2016·Anti-cancer Drugs·Esther A GuzmánAmy E Wright
Jan 11, 2018·Cancer Discovery·Annan YangAlec C Kimmelman
Citations
Dec 22, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Xin ZhangYaping Yan
Jan 11, 2020·Autophagy·Enyong DaiDaolin Tang
Nov 6, 2018·International Journal of Molecular Sciences·Xing-Xian GuoJing Li
Sep 25, 2020·Marine Drugs·Sergey A Dyshlovoy
Jan 27, 2019·Marine Drugs·Esther A Guzmán
Nov 10, 2020·Autophagy·Jingbo LiDaolin Tang
Jan 29, 2021·Journal of Biochemical and Molecular Toxicology·C R Sruthi, K G Raghu
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Taitusi TaufaRobert A Keyzers
Jan 23, 2022·Glycoconjugate Journal·Yadav Sangeeta MuthyalaiahSumathy Arockiasamy